S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway
S&P 500   5,137.08
DOW   39,087.38
QQQ   445.61
Lawyers who successfully argued Musk pay package was illegal seek $5.6 billion in Tesla stock
This is the #1 Stock to Buy for the AI Tidal Wave (Ad)
Sports analytics may be outnumbered when it comes to artificial intelligence
Chicago 'mansion' tax to fund homeless services stuck in legal limbo while on the ballot
Critical asset just had biggest fall on record (Ad)
Norway's hospitalized king gets a pacemaker in Malaysia after falling ill during vacation
Head Start preschools aim to fight poverty, but their teachers struggle to make ends meet
Critical asset just had biggest fall on record (Ad)
South Korean doctors hold massive anti-government rally over medical school recruitment plan
What to watch for as China's major political meeting of the year gets underway

HTG Molecular Diagnostics (HTGMQ) Competitors

$0.0015
0.00 (0.00%)
(As of 03/1/2024 ET)

HTGMQ vs. KLDO, VRAYQ, NOVNQ, GMVDF, STAB, IDXG, NSTG, PRPO, AXDX, and TLIS

Should you be buying HTG Molecular Diagnostics stock or one of its competitors? The main competitors of HTG Molecular Diagnostics include Kaleido Biosciences (KLDO), ViewRay (VRAYQ), NVN Liquidation (NOVNQ), G Medical Innovations (GMVDF), Statera Biopharma (STAB), Interpace Biosciences (IDXG), NanoString Technologies (NSTG), Precipio (PRPO), Accelerate Diagnostics (AXDX), and Talis Biomedical (TLIS). These companies are all part of the "medical" sector.

HTG Molecular Diagnostics vs.

HTG Molecular Diagnostics (NASDAQ:HTGMQ) and Kaleido Biosciences (NASDAQ:KLDO) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their risk, dividends, valuation, analyst recommendations, media sentiment, community ranking, earnings, profitability and institutional ownership.

81.6% of Kaleido Biosciences shares are owned by institutional investors. 2.6% of HTG Molecular Diagnostics shares are owned by insiders. Comparatively, 9.0% of Kaleido Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, HTG Molecular Diagnostics' average media sentiment score of 0.61 beat Kaleido Biosciences' score of 0.00 indicating that HTG Molecular Diagnostics is being referred to more favorably in the media.

Company Overall Sentiment
HTG Molecular Diagnostics Positive
Kaleido Biosciences Neutral

HTG Molecular Diagnostics has a beta of 3.06, suggesting that its stock price is 206% more volatile than the S&P 500. Comparatively, Kaleido Biosciences has a beta of -0.06, suggesting that its stock price is 106% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
HTG Molecular Diagnostics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Kaleido Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Company Net Margins Return on Equity Return on Assets
HTG Molecular DiagnosticsN/A N/A N/A
Kaleido Biosciences N/A N/A N/A

Kaleido Biosciences received 54 more outperform votes than HTG Molecular Diagnostics when rated by MarketBeat users.

CompanyUnderperformOutperform
HTG Molecular DiagnosticsN/AN/A
Kaleido BiosciencesOutperform Votes
54
57.45%
Underperform Votes
40
42.55%

HTG Molecular Diagnostics has higher revenue and earnings than Kaleido Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HTG Molecular Diagnostics$6.37M0.00-$21.59MN/AN/A
Kaleido Biosciences$1.10M0.00-$95.48M-$2.24N/A

Summary

HTG Molecular Diagnostics beats Kaleido Biosciences on 4 of the 7 factors compared between the two stocks.


Get HTG Molecular Diagnostics News Delivered to You Automatically

Sign up to receive the latest news and ratings for HTGMQ and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HTGMQ and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HTGMQ vs. The Competition

MetricHTG Molecular DiagnosticsAnalytical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$3,000.00$6.18B$5.09B$7.62B
Dividend YieldN/A0.39%2.82%3.87%
P/E RatioN/A11.89221.9117.05
Price / Sales0.007.743,097.17108.91
Price / Cash0.0173.9299.9255.44
Price / Book0.003.254.534.54
Net Income-$21.59M$2.58M$114.85M$211.55M
7 Day PerformanceN/A2.57%5.73%3.36%
1 Month PerformanceN/A2.26%12.81%6.70%
1 Year PerformanceN/A4.12%12.92%7.44%

HTG Molecular Diagnostics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
KLDO
Kaleido Biosciences
0 of 5 stars
$0.00
+∞
N/AN/A$4,000.00$1.10M0.0076Gap Up
VRAYQ
ViewRay
0 of 5 stars
$0.00
+∞
N/AN/A$18,000.00$102.21M0.00295Gap Up
NOVNQ
NVN Liquidation
0 of 5 stars
$0.00
+60.0%
N/AN/A$22,000.00$23.68M0.0090News Coverage
Gap Up
GMVDF
G Medical Innovations
0 of 5 stars
$0.02
flat
N/AN/A$30,000.00$4.42M0.0084Gap Up
STAB
Statera Biopharma
0 of 5 stars
$0.00
flat
N/A-97.8%$33,000.00$1.49M0.0046Gap Down
IDXG
Interpace Biosciences
0 of 5 stars
$1.09
+1.9%
N/A-12.2%$4.73M$31.84M-2.78152News Coverage
NSTG
NanoString Technologies
3.3638 of 5 stars
$0.11
-37.4%
$7.63
+7,141.2%
N/A$5.07M$127.26M-0.03550Analyst Report
Gap Down
PRPO
Precipio
0.8957 of 5 stars
$6.21
-2.1%
$40.00
+544.1%
-53.6%$8.82M$13.26M-0.8353Gap Down
AXDX
Accelerate Diagnostics
2.5633 of 5 stars
$0.97
+2.1%
N/A-80.8%$14.13M$12.00M-0.18179Short Interest ↓
Gap Up
TLIS
Talis Biomedical
0.6097 of 5 stars
$8.52
-3.3%
$5.00
-41.3%
-5.7%$15.51M$4.81M-0.20102Short Interest ↓
Positive News
Gap Down

Related Companies and Tools

This page (NASDAQ:HTGMQ) was last updated on 3/3/2024 by MarketBeat.com Staff